{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:20:57Z","timestamp":1791915657397,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011715","name":"Macmillan Cancer Support","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Significant volumes of research rely on secondary care diagnostic coding to identify comorbidities however little is known about its accuracy at a population level or if this influences subsequent analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospective observational study utilising real world data for all cancers, prostate cancer and breast cancer patients diagnosed at Leeds Cancer Centre from 2005 and 2018. Three different data definitions were used to identify patients with diabetes in each cohort: (1) clinical coding alone, (2) HbA1c blood test alone (3) either clinical coding or abnormal HbA1c. Cohort characteristics, diagnosis dates and Cox derived survival was compared across diabetes definitions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>123,841 cancer patients were identified including 13,964 with diabetes. Clinical coding failed to identify 14.6% of diabetic cancer patients with a temporal misclassification rate of 17.5%. Sole reliance on clinical coding overestimated the negative effect of DM on median survival across all cancers and 3.17 years in breast cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Clinical coding provides inaccurate diabetes diagnosis date and detection resulting in meaningful differences in analytic outcomes. This supports the use of more detailed comorbidity data definitions. Results casts doubt over research reliant on hospital clinical coding alone and the generalisability of some comorbidity and frailty scoring systems.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41416-025-03136-9","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T12:44:24Z","timestamp":1754743464000},"page":"1137-1144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Why NHS hospital co-morbidity research may be wrong: how clinical coding fails to identify the impact of diabetes mellitus on cancer survival"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4385-3153","authenticated-orcid":false,"given":"K.","family":"Zucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"McInerney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A,","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"3136_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-5347(01)65964-0","volume":"156","author":"PC Albertsen","year":"1996","unstructured":"Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol. 1996;156:127\u201332. https:\/\/doi.org\/10.1016\/S0022-5347(01)65964-0.","journal-title":"J Urol"},{"key":"3136_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/cncr.23269","volume":"112","author":"SMH Alibhai","year":"2008","unstructured":"Alibhai SMH, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G. Is there an optimal comorbidity index for prostate cancer? Cancer. 2008;112:1043\u20131050. https:\/\/doi.org\/10.1002\/cncr.23269.","journal-title":"Cancer"},{"key":"3136_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/bjs.6930","volume":"97","author":"JN Armitage","year":"2010","unstructured":"Armitage JN, Van Der Meulen JH. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. Br J Surg. 2010;97:772\u201381. https:\/\/doi.org\/10.1002\/bjs.6930.","journal-title":"Br J Surg"},{"key":"3136_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(12)60240-2.","journal-title":"Lancet"},{"key":"3136_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ejso.2014.06.001","volume":"40","author":"T Bates","year":"2014","unstructured":"Bates T, Evans T, Lagord C, Monypenny I, Kearins O, Lawrence G. A population based study of variations in operation rates for breast cancer, of comorbidity and prognosis at diagnosis: failure to operate for early breast cancer in older women. Eur J Surg Oncol. 2014;40:1230\u201336. https:\/\/doi.org\/10.1016\/j.ejso.2014.06.001.","journal-title":"Eur J Surg Oncol"},{"key":"3136_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ijsu.2012.01.007","volume":"10","author":"A Bhangu","year":"2012","unstructured":"Bhangu A, Nepogodiev D, Taylor C, Durkin N, Patel R. Accuracy of clinical coding from 1210 appendicectomies in a British district general hospital. Int J Surg. 2012;10:144\u201347. https:\/\/doi.org\/10.1016\/j.ijsu.2012.01.007.","journal-title":"Int J Surg"},{"key":"3136_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"3136_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.eururo.2014.05.029","volume":"66","author":"TJ Daskivich","year":"2014","unstructured":"Daskivich TJ, Kwan L, Dash A, Greenfield S, Litwin MS. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer. Eur Urol. 2014;66:1002\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2014.05.029.","journal-title":"Eur Urol"},{"key":"3136_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/shorts.2011.011100","volume":"2","author":"H Daultrey","year":"2011","unstructured":"Daultrey H, Gooday E, Dhatariya K. Increased length of inpatient stay and poor clinical coding: audit of patients with diabetes. JRSM Short Rep. 2011;2:1\u20136. https:\/\/doi.org\/10.1258\/shorts.2011.011100.","journal-title":"JRSM Short Rep"},{"key":"3136_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44:1055\u201368. https:\/\/doi.org\/10.1183\/09031936.00059814.","journal-title":"Eur Respir J"},{"key":"3136_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/oxfordjournals.pubmed.a024721","volume":"20","author":"J Dixon","year":"1998","unstructured":"Dixon J, Sanderson C, Elliott P, Walls P, Jones J, Petticrew M. Assessment of the reproducibility of clinical coding in routinely collected hospital activity data: a study in two hospitals. J Public Health (U Kingd). 1998;20:63\u20139. https:\/\/doi.org\/10.1093\/oxfordjournals.pubmed.a024721.","journal-title":"J Public Health (U Kingd)"},{"key":"3136_CR12","doi-asserted-by":"publisher","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. https:\/\/doi.org\/10.1097\/00005650-199801000-00004 (1998).","DOI":"10.1097\/00005650-199801000-00004"},{"key":"3136_CR13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1080\/10937404.2015.1051611.INHALATION","volume":"11","author":"W Guo","year":"2015","unstructured":"Guo W, Polich ED, Su J, Gao Y, Christopher DM, Allan AM, et al. Ageing and the epidemiology of multimorbidity Miguel. Cell Rep. 2015;11:1651\u201366. https:\/\/doi.org\/10.1080\/10937404.2015.1051611.INHALATION.","journal-title":"Cell Rep"},{"key":"3136_CR14","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00384-017-2830-8","volume":"32","author":"S Hajibandeh","year":"2017","unstructured":"Hajibandeh S, Hajibandeh S, Deering R, McEleney D, Guirguis J, Dix S, et al. Accuracy of routinely collected comorbidity data in patients undergoing colectomy: a retrospective study. Int J Colorectal Dis. 2017;32:1341\u201344. https:\/\/doi.org\/10.1007\/s00384-017-2830-8.","journal-title":"Int J Colorectal Dis"},{"key":"3136_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10029-017-1713-9","volume":"22","author":"S Hajibandeh","year":"2018","unstructured":"Hajibandeh S, Hajibandeh S, Deering R, McEleney D, Guirguis J, Dix S, et al. Accuracy of co-morbidity data in patients undergoing abdominal wall hernia repair: a retrospective study. Hernia. 2018;22:243\u201348. https:\/\/doi.org\/10.1007\/s10029-017-1713-9.","journal-title":"Hernia"},{"key":"3136_CR16","unstructured":"Home\u2014NHS Digital. (n.d.). Retrieved July 18, 2022, from https:\/\/digital.nhs.uk\/"},{"key":"3136_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60:199\u2013206. https:\/\/doi.org\/10.3399\/bjgp10X483562.","journal-title":"Br J Gen Pract"},{"key":"3136_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1046\/j.1464-4096.2001.01428.x","volume":"89","author":"HA Khwaja","year":"2002","unstructured":"Khwaja HA, Syed H, Cranston DW. Coding errors: a comparative analysis of hospital and prospectively collected departmental data. BJU Int. 2002;89:178\u201380. https:\/\/doi.org\/10.1046\/j.1464-4096.2001.01428.x.","journal-title":"BJU Int"},{"key":"3136_CR19","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3892\/ol.2015.2916","volume":"9","author":"MW Marcus","year":"2015","unstructured":"Marcus MW, Chen Y, Duffy SW, Field JK. Impact of comorbidity on lung cancer mortality\u2014a report from the liverpool lung project. Oncol Lett. 2015;9:1902\u20136. https:\/\/doi.org\/10.3892\/ol.2015.2916.","journal-title":"Oncol Lett"},{"key":"3136_CR20","unstructured":"NHS Digital. (2020, November 19). Hospital Episode Statistics. https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics."},{"key":"3136_CR21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/SLA.0000000000000851","volume":"261","author":"SAR Nouraei","year":"2015","unstructured":"Nouraei SAR, Hudovsky A, Frampton AE, Mufti U, White NB, Wathen CG, et al. A study of clinical coding accuracy in surgery: Implications for the use of administrative big data for outcomes management. Ann Surg. 2015;261:1096\u20131107. https:\/\/doi.org\/10.1097\/SLA.0000000000000851.","journal-title":"Ann Surg"},{"key":"3136_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jclinepi.2005.07.015","volume":"59","author":"M Nuttall","year":"2006","unstructured":"Nuttall M, Van Der Meulen J, Emberton M. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol. 2006;59:265\u201373. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.07.015.","journal-title":"J Clin Epidemiol"},{"key":"3136_CR23","unstructured":"Public Health England. Guidance: National Cancer Registration and Analysis Service (NCRAS). 2016. https:\/\/www.gov.uk\/guidance\/national-cancer-registration-and-analysis-service-ncras"},{"key":"3136_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/bjc.2011.310","volume":"105","author":"AL Rich","year":"2011","unstructured":"Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, et al. How do patient and hospital features influence outcomes in small-cell lung cancer in England. Br J Cancer. 2011;105:746\u201352. https:\/\/doi.org\/10.1038\/bjc.2011.310.","journal-title":"Br J Cancer"},{"key":"3136_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.kint.2017.11.020","volume":"93","author":"BC Storey","year":"2018","unstructured":"Storey BC, Staplin N, Harper CH, Haynes R, Winearls CG, Goldacre R, et al. Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy. Kidney Int. 2018;93:1165\u201374. https:\/\/doi.org\/10.1016\/j.kint.2017.11.020.","journal-title":"Kidney Int"},{"key":"3136_CR26","unstructured":"\u201cSummary of a roundtable meeting\u201d. Multiple morbidities as a global health challenge. Academy of Medical Sciences, October 2015 (2015)."},{"key":"3136_CR27","unstructured":"Trusted Research Environment service for England. (n.d.). NHS Digital. Retrieved June 23, 2022, from https:\/\/digital.nhs.uk\/coronavirus\/coronavirus-data-services-updates\/trusted-research-environment-service-for-england."},{"key":"3136_CR28","unstructured":"World Health Organisation. (2011, January 13). Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus. World Health Orgnaisation. https:\/\/www.who.int\/publications-detail-redirect\/use-of-glycated-haemoglobin-(-hba1c)-in-diagnosis-of-diabetes-mellitus."},{"key":"3136_CR29","unstructured":"World Health Organisation. International Disease Classification. 2020. http:\/\/www.who.int\/classifications\/icd\/en\/."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03136-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:24:06Z","timestamp":1760624646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03136-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["3136"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03136-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study methods used comply with all relevant guidelines and regulations. The study received ethical approval following review from the UK Health Regulatory Authority and Care Research Wales under IRAS 277122 REC Reference 20\/HRA\/1165. As the study used deidentified data only direct informed consent was not required for data registered opt outs were respected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}